Detection of subclinical cardiotoxicity in sarcoma patients receiving continuous doxorubicin infusion or pre-treatment with dexrazoxane before bolus doxorubicin

BACKGROUND: Continuous infusion of doxorubicin or dexrazoxane pre-treatment prior to bolus doxorubicin are proven strategies to protect against doxorubicin-induced cardiotoxicity. Recently, global longitudinal peak systolic strain (GLS) measured with speckle tracking echocardiography (STE) and high-...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jieli, Chang, Hui-Ming, Banchs, Jose, Araujo, Dejka M., Hassan, Saamir A., Wagar, Elizabeth A., Yeh, Edward T. H., Meng, Qing H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7048030/
https://www.ncbi.nlm.nih.gov/pubmed/32154027
http://dx.doi.org/10.1186/s40959-019-0056-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7048030/
https://www.ncbi.nlm.nih.gov/pubmed/32154027
http://dx.doi.org/10.1186/s40959-019-0056-3

Ejemplares similares